Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
Therapeutics and Clinical Risk Management, 11/04/09
Wraith JE et al. – Findings demonstrated clinically relevant beneficial effects of miglustat on neurological disease progression in adult, juvenile and pediatric patients with NP–C, particularly those diagnosed in late childhood and in juveniles and adults, compared with those diagnosed in early childhood. With the approval of miglustat, treatment of patients with NP–C can now be aimed toward stabilizing neurological disease, which is likely the best attainable therapeutic goal for this disorder.
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Narcolepsy: Clinical Decision Making for the Primary Care Physician
Southern Medical Journal, 12/04/09
Cognitive-behavioral therapy for sleep abnormalities of chronic pain patients
Current Rheumatology Reports, 12/04/09
Neurodevelopmental Outcome of Infants With Unilateral or Bilateral Periventricular Hemorrhagic Infarction
Pediatrics, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


